ObLiGaRe doxycycline Inducible (ODIn) Cas9 system driving pre-clinical drug discovery, from design to cancer treatment
Lundin, A.; Porritt, M. J.; Jaiswal, H.; Seeliger, F.; Johansson, C.; Wahad Bidar, A.; Badertscher, L.; Davies, E. J.; Hardaker, E.; Martins, C. P.; Admyre, T.; Taheri-Ghahfarokhi, A.; Bradley, J.; Schantz, A.; Alaeimahabadi, B.; Clausen, M.; Xiufeng, X.; Mayr, L.; Nitsch, R.; Bohlooly-Y, M.; Barry, S. T.; Maresca, M.
Show abstract
The CRISPR-Cas9 system has increased the speed and precision of genetic editing in cells and animals. However, model generation for drug development is still expensive and time-consuming, demanding more target flexibility and faster turnaround times with high reproducibility. We have generated a tightly controlled ObLiGaRe doxycycline inducible SpCas9 (ODInCas9) transgene. Targeted ObLiGaRe resulted in functional integration into both human and mouse cells culminating in the generation of the ODInCas9 mouse. Genomic editing can be performed in cells of various tissue origins without any detectable gene editing in the absence of doxycycline. Somatic in vivo editing can model non-small cell lung cancer (NSCLC) adenocarcinomas, enabling treatment studies to validate the efficacy of candidate drugs. The ODInCas9 mouse can be utilized for robust and tunable genome editing allowing for flexibility, speed and uniformity at reduced cost, leading to high throughput and practical preclinical in vivo therapeutic testing.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Preclinical lentiviral vector-mediated hematopoietic stem and progenitor cell gene therapy corrects Pompe disease-related muscle and neurological manifestations 95%
- TALEN-mediated intron editing of HSPCs enables transgene expression restricted to the myeloid lineage 94%
- AAV-mediated gene therapy for Sialidosis 94%
Similar papers in this journal
- CRISPR/Cas9-Mediated Excision of ALS/FTD-Causing Hexanucleotide Repeat Expansion in C9ORF72 rescues major disease mechanisms in vivo and in vitro 95%
- RNAi-mediated rheostat for dynamic control of AAV-delivered transgenes 95%
- Simultaneous inhibition of DNA-PK and Pol{Theta} improves integration efficiency and precision of genome editing 94%
Similar papers in this journal
- Anti-cancer compound screening identifies Aurora Kinase A inhibition as a means to favor CRISPR/Cas9 gene correction over knock-out 95%
- Characterization of Poldip2 knockout mice: avoiding incorrect gene targeting 93%
- 3D imaging of colorectal cancer organoids identifies responses to Tankyrase inhibitors 93%
Similar papers in this journal
- Highly efficient generation of isogenic pluripotent stem cell models using prime editing 95%
- Whole brain delivery of an instability-prone Mecp2 transgene improves behavioral and molecular pathological defects in mouse models of Rett syndrome 95%
- Engineered natural killer cells impede the immunometabolic CD73-adenosine axis in solid tumors 94%
Similar papers in this journal
- Cell type specific long non-coding RNA targets identified by integrative analysis of single-cell and bulk colorectal cancer transcriptomes 94%
- GRP78 promotes stemness in normal and neoplastic cells 94%
- GFAP splice variants fine-tune glioma cell invasion and tumour dynamics by modulating migration persistence 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.